REGENXBIO Inc. - Laporan Laba Rugi (TTM)

REGENXBIO Inc.
US ˙ NasdaqGS ˙ US75901B1070

Laporan Laba Rugi (TTM)

Laporan Laba Rugi REGENXBIO Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 145 155 156 161 93 470 474 484 480 113 110 97 99 90 87 89 84 83 157 156
Change (%) 6.68 0.80 3.51 -42.25 405.01 0.71 2.24 -0.88 -76.52 -2.73 -11.56 2.48 -9.19 -3.90 2.67 -5.30 -1.18 88.07 -0.60
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 182 202 206 219 220 233 251 278 284 55 236 222 278 37 34 27 -84 34 31 27
Change (%) 10.89 2.04 6.26 0.29 6.19 7.53 10.95 1.89 -80.76 332.37 -5.85 25.14 -86.61 -9.41 -20.06 -410.48 -140.12 -7.76 -11.67
% of Revenue 125.73 130.69 132.30 135.82 235.86 49.60 52.96 57.46 59.07 48.39 215.09 228.97 279.60 41.24 38.87 30.26 -99.22 40.28 19.76 17.56
Gross Operating Profit -37 -47 -50 -58 -127 237 223 206 196 58 -126 -71 -126 53 53 62 168 50 126 128
Change (%) 27.26 6.09 14.78 119.04 -287.36 -6.01 -7.56 -4.62 -70.39 -316.90 -44.01 78.38 -142.08 -0.03 17.13 170.54 -70.38 152.72 2.13
% of Revenue -25.73 -30.69 -32.30 -35.82 -135.86 50.40 47.04 42.54 40.93 51.61 -115.09 -72.86 -126.82 58.76 61.13 69.74 199.22 59.72 80.24 82.44
SG&A 69 71 75 78 81 77 81 84 78 85 86 88 91 88 83 79 75 72 74 75
Change (%) 4.18 4.52 3.77 4.10 -4.92 5.84 2.96 -7.04 9.67 0.37 3.35 2.44 -3.12 -4.95 -5.80 -4.66 -4.44 2.87 1.40
% of Revenue 47.36 46.26 47.96 48.09 86.68 16.32 17.15 17.27 16.20 75.65 78.07 91.23 91.20 97.29 96.22 88.28 88.88 85.95 47.01 47.95
R&D 242 52 107 52 229 229 226 333 209 209 217
Change (%) -78.37 103.76 -50.92 337.15 0.00 -1.37 47.26 -37.38 0.00 4.26
% of Revenue 215.09 47.83 110.20 52.78 254.06 264.36 253.94 394.87 250.24 133.06 139.55
OpEx 251 274 281 297 300 310 332 362 362 368 360 348 354 355 347 332 324 315 314 320
Change (%) 9.17 2.77 5.64 1.06 3.32 6.97 9.07 0.07 1.59 -2.30 -3.14 1.58 0.23 -2.23 -4.25 -2.29 -3.03 -0.16 2.01
% of Revenue 173.09 177.14 180.60 184.31 322.54 65.99 70.09 74.77 75.48 326.55 328.02 359.23 356.10 393.02 399.83 372.86 384.70 377.51 200.41 205.66
Operating Income -106 -119 -126 -136 -207 160 142 122 118 -255 -250 -251 -254 -264 -260 -243 -240 -231 -157 -165
Change (%) 12.58 5.32 8.28 52.44 -177.19 -11.43 -13.77 -3.68 -316.99 -2.10 0.55 1.24 3.90 -1.66 -6.56 -1.19 -3.68 -31.95 4.60
% of Revenue -73.09 -77.14 -80.60 -84.31 -222.54 34.01 29.91 25.23 24.52 -226.55 -228.02 -259.23 -256.10 -293.02 -299.83 -272.86 -284.70 -277.51 -100.41 -105.66
Interest Expense -1 -7 -14 -21 -26 -26 -26 -25 -23 -20 -14 -10 -7 -6 -5 -5 -13 -19 -30
Change (%) 869.26 85.19 48.48 27.88 -2.18 1.92 -2.88 -8.61 -14.51 -28.87 -30.62 -30.04 -11.40 -11.04 -14.86 174.90 52.11 54.76
% of Revenue -0.50 -4.80 -8.58 -22.06 -5.59 -5.43 -5.41 -5.30 -20.63 -18.13 -14.58 -9.87 -7.60 -7.01 -6.07 -5.46 -15.19 -12.29 -19.13
Net Income -91 -111 -121 -145 -212 128 101 91 74 -280 -270 -274 -261 -263 -260 -241 -239 -227 -158 -176
Change (%) 21.62 9.08 19.68 46.27 -160.18 -20.79 -10.41 -18.83 -480.68 -3.58 1.44 -4.97 1.13 -1.27 -7.33 -0.94 -4.90 -30.56 11.34
% of Revenue -63.13 -71.98 -77.89 -90.05 -228.08 27.18 21.38 18.73 15.34 -248.68 -246.50 -282.72 -262.18 -291.99 -299.97 -270.74 -283.19 -272.54 -100.62 -112.70

Source: Capital IQ

Other Listings
DE:RB0 € 8.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista